Schaeffer's Top Stock Picks for '25

Dow Jones Industrial Average Slips as Oil Prices Sink

Why Small-Cap Stocks Are Extremely Vulnerable Right Now

Mar 14, 2017 at 11:58 AM
facebook X logo linkedin


The Dow Jones Industrial Average (DJIA) is well below breakeven at midday, with stocks suffering broad losses ahead of today's Fed meeting kickoff. Sliding oil prices are adding to the bearish backdrop, with Exxon Mobil Corporation (NYSE:XOM) and Chevron Corporation (NYSE:CVX) among the worst Dow performers today. At last glance, April-dated crude futures were down another 2.3% at $47.28 per barrel -- touching fresh three-month lows, and on pace for a seventh straight drop. The Nasdaq Composite (COMP) and S&P 500 Index (SPX) are moving lower, too, putting the latter index on pace to close below a key trendline for the first time in nearly two months. 

Continue reading for more on today's market -- and don't miss:

  • Why small-cap stocks look extremely vulnerable right now, according to founder and CEO Bernie Schaeffer.
  • Analysts: This "underappreciated" healthcare stock could triple. 
  • Plus, Valeant put options pop; J C Penney's new low; and a big biotech loser. 

stock market news today

Among the names seeing accelerated options trading today is Valeant Pharmaceuticals Intl Inc (NYSE:VRX), after investor Bill Ackman threw in the towel on the drug stock. While call volume is also accelerated, puts are trading at four times the normal pace for this point in the day. The most popular option overall is the March 10 put, which is seeing a mix of activity. Further down the list, it seems option bears are buying to open VRX's March 10.50 put, expecting further losses by week's end, when the contracts expire. The stock was down 11% at $10.79 at last check, after touching an eight-year low of $10.50. 

J C Penney Company Inc (NYSE:JCP) is near the bottom of the New York Stock Exchange today, as the retail stock continues its downtrend. Specifically, JCP stock was last seen down 1.8% at $5.89, and earlier hit a three-year low of $5.85. The shares have now shed 45% since their December high, but any remaining bulls may be hoping for JCP to once again bounce from the $6 area. 

jcp stock

A big loser on the Nasdaq is Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), after the drug company's fourth-quarter earnings report. Down 13.3% today at $12.81, the shares are short-sale restricted, and on pace for their lowest close since May.

Don't miss the stock market's big finish. Sign up now for Schaeffer's Market Recap.

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter